These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4677171)

  • 1. [Methods of administration of antineoplastic drugs based on its concentration in the blood and various organs--cyclophosphamide].
    Kato T; Yakushiji M; Matsumoto M; Nunotani H
    Igaku Kenkyu; 1972 Nov; 42(3):159-66. PubMed ID: 4677171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the concentration of cyclophosphamide (Endoxan) in the blood and tissues in patients with gynecological cancer, with special reference to optimum dosage].
    Tashiro K
    Gan No Rinsho; 1969 Apr; 15(4):433-8. PubMed ID: 5817055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of brain tumors, with reference to the selection of carcinostatics for intrathecal administration and the distribution of concentration of carcinostatics in various administrations].
    Jinnai D; Mogami H; Higashi H; Hayakawa T; Kuroda R
    No To Shinkei; 1967 Apr; 19(4):333-7. PubMed ID: 6072672
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies of the chemotherapy of brain tumors. 1. Distribution of cytostatic agents in the serum, cerebrospinal fluid and brain tissue after intravenous, intracarotid and intrathecal administration.
    Yamada R; Kanai N; Kuroda R; Hayakawa T; Higashi H
    Med J Osaka Univ; 1968 Mar; 18(4):373-88. PubMed ID: 5755297
    [No Abstract]   [Full Text] [Related]  

  • 5. The embryotoxic effects of cyclophosphamide in rabbits tested in vivo by i.v. injection and by the yolk-sac method.
    Claussen U; Krengel HG; Schrörs HJ
    Arzneimittelforschung; 1980; 30(9):1585-8. PubMed ID: 7193029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rate of cyclophosphamide activation.
    Syrkin AB; Zaitzeva LA
    Neoplasma; 1970; 17(4):377-81. PubMed ID: 5506443
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.
    Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Cancer Res; 1973 Oct; 33(10):2218-20. PubMed ID: 4741927
    [No Abstract]   [Full Text] [Related]  

  • 9. Grouping of anticancer drugs based on administration method-related toxicity patterns in rats.
    Mizushima Y; Li H; Sassa K; Fujishita T; Oosaki R; Kobayashi M
    Anticancer Res; 1997; 17(6D):4611-4. PubMed ID: 9494577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple and sensitive method for the determination of cyclophosphamide by means of a nitrogen--phosphorus-selective detector.
    Facchinetti T; D'Incalci M; Martelli G; Cantoni L; Belvedere G; Salmona M
    J Chromatogr; 1978 Mar; 145(2):315-8. PubMed ID: 649726
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
    Struck RF; Alberts DS
    Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide effect on changes in rabbit peripheral blood in the development period.
    Maślińska D; Swierczyńska A; Koch I
    Acta Physiol Pol; 1983; 34(1):85-90. PubMed ID: 6637534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarographic and colorimetric methods for determination of cyclophosphamide.
    Ellaithy MM; El-Tarras MF; Tadros NB; Amer MM
    J Assoc Off Anal Chem; 1984; 67(4):679-81. PubMed ID: 6469894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of therapeutic doses of endoxan on the digestive tract].
    Wieczorek M; Stadnik J
    Pol Przegl Chir; 1970 Aug; 42(8):1180-7. PubMed ID: 5472519
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of squalene on cyclophosphamide-induced toxicity.
    Senthilkumar S; Devaki T; Manohar BM; Babu MS
    Clin Chim Acta; 2006 Feb; 364(1-2):335-42. PubMed ID: 16150433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous pulse versus oral administration of cyclophosphamide: comment on the article by Haubitz et al.
    Savage CO; Jayne DR
    Arthritis Rheum; 1999 Sep; 42(9):2019-20. PubMed ID: 10513825
    [No Abstract]   [Full Text] [Related]  

  • 18. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of hepatic cancer--evaluation of local administration via porta vain].
    Hayashi S; Sano H; Takemae T; Kobayashi I
    Geka Chiryo; 1970 Dec; 23(6):634-44. PubMed ID: 5536935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.